Kisspeptin-10
Intravenous (into a vein)Human study reference
Research reference
Human study
Kisspeptin-10 hormone-response experiment
IV boluses of 0.01–3 mcg/kg; separate continuous-infusion experiments
Hormones sampled over minutes to 22.5 hours
George et al., JCEM (2011) ↗When results may show
- When change was measured
- LH and testosterone responses were measured, not pregnancy, sustained symptom change or long-term benefit.
- When to assess
- Hormones sampled over minutes to 22.5 hours
- Conditions and limitations
- Healthy adult men; small dose-response and infusion groups. Weight-based IV research cannot define a fixed under-the-skin fertility or testosterone protocol.
- When to stop
- The measured study window is not a validated personal quit rule. Do not increase or prolong exposure because an expected result is absent; severe or persistent reactions need prompt clinical review.
Sources: George et al., JCEM (2011)
Research timing is descriptive, not a promise or personal instruction. A severe or persistent reaction needs prompt clinical review. This is not medical advice.
Key properties
- Formula
- C63H83N17O14
- Mol. weight
- 1,302.4 Da
- CAS
- 374675-21-5
- PubChem CID
- 25240297
External references
Modelled level — 3x per week
1× is the peak after a single dose.
- Steady-state peak
- 0.91× single dose
- Time to steady state
- 1hours
- Administrations
- 3/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- George et al., JCEM (2011)Weight-based IV research cannot define a fixed under-the-skin fertility or testosterone protocol.